Cargando…
PLEKHG5 is stabilized by HDAC2-related deacetylation and confers sorafenib resistance in hepatocellular carcinoma
Sorafenib is the first FDA-approved first-line targeted drug for advanced HCC. However, resistance to sorafenib is frequently observed in clinical practice, and the molecular mechanism remains largely unknown. Here, we found that PLEKHG5 (pleckstrin homology and RhoGEF domain containing G5), a RhoGE...
Autores principales: | Sha, Yu, Pan, Mingang, Chen, Yunmeng, Qiao, Liangjun, Zhou, Hengyu, Liu, Dina, Zhang, Wenlu, Wang, Kai, Huang, Luyi, Tang, Ni, Qiu, Jianguo, Huang, Ailong, Xia, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227013/ https://www.ncbi.nlm.nih.gov/pubmed/37248230 http://dx.doi.org/10.1038/s41420-023-01469-z |
Ejemplares similares
-
RAD51 Inhibition Shows Antitumor Activity in Hepatocellular Carcinoma
por: Pan, Mingang, et al.
Publicado: (2023) -
Vascular histone deacetylation by pharmacological HDAC inhibition
por: Rafehi, Haloom, et al.
Publicado: (2014) -
HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma
por: Zhang, Ruixue, et al.
Publicado: (2020) -
Deacetylation of Glutaminase by HDAC4 contributes to Lung Cancer Tumorigenesis
por: Wang, Tao, et al.
Publicado: (2022) -
GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis
por: Wang, Qiujie, et al.
Publicado: (2021)